Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral loratadine disintegrating tablet and its prepn

A technology of orally disintegrating tablets and loratadine, which is applied in pill delivery, respiratory diseases, drug combination, etc., can solve the problems of high equipment cost, long disintegration time, and short disintegration time, and achieves a simple and convenient preparation method , Guaranteed therapeutic effect and short disintegration time

Inactive Publication Date: 2006-03-01
CHONGQING CONQUER PHARML
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is difficult for the elderly, children and those with dysphagia to swallow ordinary tablets and capsules, especially long-term use will lead to poor compliance of patients, so that the therapeutic effect cannot be guaranteed; and syrups are inconvenient to carry
[0005] Of course, there are also people of insight who have done research on the preparation of orally disintegrating tablets of loratadine: in order to achieve the purpose of short disintegration time, researchers have used freeze-drying methods to prepare this dosage form, using this method It can achieve the purpose of disintegration time of less than 10 seconds, but the processing equipment of this type of preparation method is very expensive, and the equipment cost of the enterprise is high; in order to reduce costs, if the wet granulation of common ordinary tablets is adopted, the disintegration of the existing formula It takes a long time (<40 seconds) and cannot achieve satisfactory results, so it is in a dilemma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: A loratadine orally disintegrating tablet, which is characterized in that it is composed of 11% loratadine as the main drug, 22% microcrystalline cellulose as filler and 56% mannitol as the disintegrating tablet. The low-substituted hydroxypropyl cellulose 8% as the antidote, the aspartame 2% as the flavoring agent, and the magnesium stearate, polyethylene glycol 6000 and talc as the lubricant accounted for 0.3% of the dry particles. %, 0.5%, 0.2%.

[0037] The specific preparation method is as follows:

[0038] First, the above-mentioned ingredients are pretreated by drying, crushing, sieving, etc.; mixing the pretreated main medicine, filler, flavoring agent and 6% disintegrant low-substituted hydroxypropyl cellulose; Add water to make soft material; use a 24-mesh sieve to granulate; dry the obtained granules at 50°C, when they are nearly dry, sizing, and then continue to dry to meet the requirements; and then in the dried granules, according to the above compo...

Embodiment 2

[0039] Example 2: Loratadine orally disintegrating tablet, wherein the proportion of each component is the same as that of Example 1; the preparation method is directly prepared by powder compression method.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to loratadine medicine, and is especially oral loratadine disintegrating tablet for treating allergic diseases and its preparation process. The oral loratadine disintegrating tablet consists of loratadine 11 wt%, micro crystal cellulose 56 wt%, mannitol 22 wt%, low substituted hydroxypropyl cellulose 8 wt%, and aspartame 2 wt%, except lubricant comprising magnesium stearate, polyglycol-6000 and talcum. The preparation process includes the pre-treatment of the components, mixing, pelletizing, drying, further mixing with lubricant, and tabletting. The present invention has short disintegrating time and easy taking.

Description

Technical field [0001] The invention relates to a loratadine medicament, in particular to a loratadine orally disintegrating tablet for treating allergic diseases and a preparation method thereof. Background technique [0002] Loratadine, the chemical name is: 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptyl[1,2-b]pyridine-11-ene)-1 -Ethyl piperidine carboxylate. It was developed by Schering-Plough of the United States and first went public in 1988. It is now on the market in 89 countries and sold as over-the-counter drugs in 15 countries. In recent years, the sales of loratadine in the international market have grown rapidly, and it has become the world's best-selling antihistamine. [0003] Loratadine is a new oral, potent and long-acting tricyclic antihistamine. Its pharmacological effects include: ①Long-acting, strong and specific competition for peripheral H1 receptors, blocking the effect of histamine; ②Inhibiting the immune release of inflammatory mediators; ③Anti-allergi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4545A61K9/20A61P11/02A61P37/08
Inventor 王从芬陈艳秋
Owner CHONGQING CONQUER PHARML
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products